| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adalimumab biosimilar in inflammatory bowel disease
|
Fiorino, Gionata
|
|
|
|
10 |
p. 775-776
|
artikel
|
| 2 |
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial
|
Klaver, Charlotte E L
|
|
2019
|
|
10 |
p. 761-770
|
artikel
|
| 3 |
A global investment case for hepatitis B elimination: a modelling study
|
Seaman, Christopher P
|
|
|
|
10 |
p. 932-942
|
artikel
|
| 4 |
Alcohol: are we enjoying responsibly?
|
The Lancet Gastroenterology & Hepatology,
|
|
2017
|
|
10 |
p. 691-
1 p.
|
artikel
|
| 5 |
All roads lead to the gut–brain microbiome network
|
Schellekens, Harriet
|
|
|
|
10 |
p. 912
|
artikel
|
| 6 |
A model of the economic benefits of global hepatitis C elimination: an investment case
|
Scott, Nick
|
|
|
|
10 |
p. 940-947
|
artikel
|
| 7 |
A new bile acid treatment for non-alcoholic fatty liver disease
|
Chan, Wah Kheong
|
|
2019
|
|
10 |
p. 747-749
|
artikel
|
| 8 |
Appendectomy? Decisions, decisions…
|
Mohammadi, Dara
|
|
2017
|
|
10 |
p. 703-
1 p.
|
artikel
|
| 9 |
A procalcitonin-based algorithm to guide antibiotic use in patients with acute pancreatitis (PROCAP): a single-centre, patient-blinded, randomised controlled trial
|
Siriwardena, Ajith K
|
|
|
|
10 |
p. 913-921
|
artikel
|
| 10 |
A textbook for the liver decade
|
Mehta, Gautam
|
|
2017
|
|
10 |
p. 706-
1 p.
|
artikel
|
| 11 |
Axing of Public Health England: disease prevention in limbo
|
The Lancet Gastroenterology & Hepatology,
|
|
|
|
10 |
p. 875
|
artikel
|
| 12 |
Badass
|
Ranscombe, Peter
|
|
|
|
10 |
p. 910
|
artikel
|
| 13 |
Blood-based colorectal cancer screening: are we ready for the next frontier?
|
Wang, Christina P
|
|
|
|
10 |
p. 870-872
|
artikel
|
| 14 |
Bodily Functions and Where to Find Them: comedy with a serious message
|
Ranscombe, Peter
|
|
2019
|
|
10 |
p. 760
|
artikel
|
| 15 |
Can we treat visceral hypersensitivity in functional abdominal pain?
|
van Tilburg, Miranda A L
|
|
2017
|
|
10 |
p. 694-695
2 p.
|
artikel
|
| 16 |
CEND-1: a game changer for pancreatic cancer chemotherapy?
|
Springfeld, Christoph
|
|
|
|
10 |
p. 900-902
|
artikel
|
| 17 |
Challenges in the management of inflammatory bowel disease in sub-Saharan Africa
|
Watermeyer, Gillian
|
|
|
|
10 |
p. 962-972
|
artikel
|
| 18 |
Chemotherapy for pancreatic cancer: the rise of multidrug regimens
|
Malka, David
|
|
2018
|
|
10 |
p. 659-660
|
artikel
|
| 19 |
Clinical research: further COVID-19 collateral damage
|
The Lancet Gastroenterology & Hepatology,
|
|
|
|
10 |
p. 875
|
artikel
|
| 20 |
Computer-aided detection versus advanced imaging for detection of colorectal neoplasia: a systematic review and network meta-analysis
|
Spadaccini, Marco
|
|
|
|
10 |
p. 793-802
|
artikel
|
| 21 |
Correction to Lancet Gastroenterol Hepatol 2018; 3: 593–95
|
|
|
2018
|
|
10 |
p. e5
|
artikel
|
| 22 |
Correction to Lancet Gastroenterol Hepatol 2019; 4: 760
|
|
|
2019
|
|
10 |
p. e9
|
artikel
|
| 23 |
Correction to Lancet Gastroenterol Hepatol 2021; 6: 784–92
|
|
|
|
|
10 |
p. e6
|
artikel
|
| 24 |
Country, regional, and global estimates for lactose malabsorption in adults: a systematic review and meta-analysis
|
Storhaug, Christian Løvold
|
|
2017
|
|
10 |
p. 738-746
9 p.
|
artikel
|
| 25 |
Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement
|
Eslam, Mohammed
|
|
|
|
10 |
p. 864-873
|
artikel
|
| 26 |
Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium
|
Shen, Bo
|
|
|
|
10 |
p. 826-849
|
artikel
|
| 27 |
Disparities in gastroenterology grand rounds speakerships in the USA
|
Peraza, Jellyana
|
|
|
|
10 |
p. 781-782
|
artikel
|
| 28 |
Diversity, equity, and inclusion in gastroenterology training: a call to action
|
Pointer, Stephanie D
|
|
|
|
10 |
p. 904-906
|
artikel
|
| 29 |
Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C?
|
Palayew, Adam
|
|
|
|
10 |
p. 948-953
|
artikel
|
| 30 |
Drinking to death: the changing face of liver disease
|
The Lancet Gastroenterology & Hepatology,
|
|
2018
|
|
10 |
p. 655
|
artikel
|
| 31 |
Dual αV-integrin and neuropilin-1 targeting peptide CEND-1 plus nab-paclitaxel and gemcitabine for the treatment of metastatic pancreatic ductal adenocarcinoma: a first-in-human, open-label, multicentre, phase 1 study
|
Dean, Andrew
|
|
|
|
10 |
p. 943-951
|
artikel
|
| 32 |
Effect of COVID-19 lockdown on alcohol consumption in patients with pre-existing alcohol use disorder
|
Kim, Jin Un
|
|
|
|
10 |
p. 886-887
|
artikel
|
| 33 |
Efficacy and safety of spore-forming probiotics in the treatment of functional dyspepsia: a pilot randomised, double-blind, placebo-controlled trial
|
Wauters, Lucas
|
|
|
|
10 |
p. 784-792
|
artikel
|
| 34 |
Efficacy, immunogenicity, and safety of a parenteral vaccine against Helicobacter pylori in healthy volunteers challenged with a Cag-positive strain: a randomised, placebo-controlled phase 1/2 study
|
Malfertheiner, Peter
|
|
2018
|
|
10 |
p. 698-707
|
artikel
|
| 35 |
Efficacy of psychological therapies in people with inflammatory bowel disease: a systematic review and meta-analysis
|
Riggott, Christy
|
|
|
|
10 |
p. 919-931
|
artikel
|
| 36 |
Emerging non-invasive approaches for diagnosis and monitoring of portal hypertension
|
Qi, Xiaolong
|
|
2018
|
|
10 |
p. 708-719
|
artikel
|
| 37 |
Endoscopic features of gastrointestinal amyloid light-chain amyloidosis
|
Latorre, Gonzalo
|
|
|
|
10 |
p. 874
|
artikel
|
| 38 |
Endoscopic versus percutaneous biliary drainage in patients with resectable perihilar cholangiocarcinoma: a multicentre, randomised controlled trial
|
Coelen, Robert J S
|
|
2018
|
|
10 |
p. 681-690
|
artikel
|
| 39 |
Ensuring patients with malignant bowel obstruction are central in research and clinical decisions
|
Boland, Jason W
|
|
|
|
10 |
p. 863-864
|
artikel
|
| 40 |
Expanding community engagement and advocacy in chronic viral hepatitis
|
Kpokiri, Eneyi E
|
|
|
|
10 |
p. 902-904
|
artikel
|
| 41 |
Food as a global health and social priority
|
The Lancet Gastroenterology & Hepatology,
|
|
|
|
10 |
p. 861
|
artikel
|
| 42 |
Future directions in therapeutic gastrointestinal endoscopy
|
Rees, Colin J
|
|
2018
|
|
10 |
p. 663-664
|
artikel
|
| 43 |
Gavi's green light for hepatitis B birth dose vaccination in Africa
|
Adepoju, Paul
|
|
|
|
10 |
p. 875
|
artikel
|
| 44 |
Global burden of atherosclerotic cardiovascular disease in people with hepatitis C virus infection: a systematic review, meta-analysis, and modelling study
|
Lee, Kuan Ken
|
|
2019
|
|
10 |
p. 794-804
|
artikel
|
| 45 |
Global burden of occult hepatitis B virus infection: where we are and what to do
|
Pollicino, Teresa
|
|
|
|
10 |
p. 899-900
|
artikel
|
| 46 |
Global hepatitis C elimination: an investment framework
|
Pedrana, Alisa
|
|
|
|
10 |
p. 927-939
|
artikel
|
| 47 |
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
|
|
|
|
|
10 |
p. 879-907
|
artikel
|
| 48 |
Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis
|
Oka, Priya
|
|
|
|
10 |
p. 908-917
|
artikel
|
| 49 |
Global prevalence of irritable bowel syndrome: time to consider factors beyond diagnostic criteria?
|
Vasant, Dipesh H
|
|
|
|
10 |
p. 879-880
|
artikel
|
| 50 |
Halo sign and araneid limb-like sign in eosinophilic enteritis
|
Huang, Xing
|
|
|
|
10 |
p. 954
|
artikel
|
| 51 |
HCV eradication in chronic kidney disease: ready for prime time?
|
Bruchfeld, Annette
|
|
|
|
10 |
p. 880-882
|
artikel
|
| 52 |
HCV-positive organ transplants in HCV-negative recipients
|
Samuel, Didier
|
|
2019
|
|
10 |
p. 745-747
|
artikel
|
| 53 |
Hepatitis C and the absence of genomic data in low-income countries: a barrier on the road to elimination?
|
Niebel, Marc
|
|
2017
|
|
10 |
p. 700-701
2 p.
|
artikel
|
| 54 |
How can I improve my gut health if I am on a special diet?
|
Staudacher, Heidi M
|
|
|
|
10 |
p. 877
|
artikel
|
| 55 |
How should we drain malignant obstruction at the liver hilum?
|
Bridgewater, John
|
|
2018
|
|
10 |
p. 657-658
|
artikel
|
| 56 |
IBD in the COVID-19 era: the value of international collaboration
|
Brenner, Erica J
|
|
|
|
10 |
p. 887-888
|
artikel
|
| 57 |
Idiopathic recurrent acute pancreatitis
|
Guda, Nalini M
|
|
2018
|
|
10 |
p. 720-728
|
artikel
|
| 58 |
Improving global digestive health: the gastroenterologists' role
|
Chudy-Onwugaje, Kenechukwu
|
|
|
|
10 |
p. 882-883
|
artikel
|
| 59 |
Indocyanine green fluorescence imaging in colorectal surgery: overview, applications, and future directions
|
Keller, Deborah S
|
|
2017
|
|
10 |
p. 757-766
10 p.
|
artikel
|
| 60 |
Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study
|
Javle, Milind
|
|
|
|
10 |
p. 803-815
|
artikel
|
| 61 |
Infigratinib in pretreated cholangiocarcinoma with FGFR2 fusions or rearrangements
|
Neuzillet, Cindy
|
|
|
|
10 |
p. 773-775
|
artikel
|
| 62 |
Inflammatory bowel disease in sub-Saharan Africa: epidemiology, risk factors, and challenges in diagnosis
|
Watermeyer, Gillian
|
|
|
|
10 |
p. 952-961
|
artikel
|
| 63 |
Integrated care for disorders of gut–brain interaction
|
Chey, William D
|
|
|
|
10 |
p. 876-877
|
artikel
|
| 64 |
Integration of public health measures for NAFLD into India's national programme for NCDs
|
Sarin, Shiv Kumar
|
|
|
|
10 |
p. 777-778
|
artikel
|
| 65 |
Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial
|
Stevens, Toer W
|
|
|
|
10 |
p. 900-907
|
artikel
|
| 66 |
Living with hepatitis C
|
Niebel, Marc
|
|
2017
|
|
10 |
p. 705-
1 p.
|
artikel
|
| 67 |
Making new gut buddies at the Edinburgh Festival Fringe
|
Ranscombe, Peter
|
|
2019
|
|
10 |
p. 759-760
|
artikel
|
| 68 |
MetALD: new opportunities to understand the role of alcohol in steatotic liver disease
|
Israelsen, Mads
|
|
|
|
10 |
p. 866-868
|
artikel
|
| 69 |
More questions regarding HIPEC in colorectal carcinomatosis
|
Johnson, Benny
|
|
2019
|
|
10 |
p. 744-745
|
artikel
|
| 70 |
My life with achalasia
|
Lawal, Elijah
|
|
2019
|
|
10 |
p. 758-759
|
artikel
|
| 71 |
Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial
|
Reni, Michele
|
|
2018
|
|
10 |
p. 691-697
|
artikel
|
| 72 |
NASH drug treatment development: challenges and lessons
|
Tilg, Herbert
|
|
|
|
10 |
p. 943-954
|
artikel
|
| 73 |
Neurostimulation for abdominal pain-related functional gastrointestinal disorders in adolescents: a randomised, double-blind, sham-controlled trial
|
Kovacic, Katja
|
|
2017
|
|
10 |
p. 727-737
11 p.
|
artikel
|
| 74 |
New WHO guidance for country validation of viral hepatitis B and C elimination
|
Easterbrook, Philippa
|
|
|
|
10 |
p. 778-780
|
artikel
|
| 75 |
New York State announces initiative to eliminate hepatitis C
|
Nelson, Roxanne
|
|
2018
|
|
10 |
p. 666
|
artikel
|
| 76 |
NHS England faces emergency in parenteral nutrition supplies
|
The Lancet Gastroenterology & Hepatology,
|
|
2019
|
|
10 |
p. 743
|
artikel
|
| 77 |
Nigeria's complicated hepatitis burden
|
Abutu, Alex
|
|
2018
|
|
10 |
p. 669
|
artikel
|
| 78 |
Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial
|
Traussnigg, Stefan
|
|
2019
|
|
10 |
p. 781-793
|
artikel
|
| 79 |
One step closer to elimination of hepatitis C in Egypt
|
Esmat, Gamal
|
|
2018
|
|
10 |
p. 665
|
artikel
|
| 80 |
Organ donation: presumed consent is not enough
|
The Lancet Gastroenterology & Hepatology,
|
|
2018
|
|
10 |
p. 655
|
artikel
|
| 81 |
PPAR agonists for primary biliary cholangitis
|
Gossard, Andrea A
|
|
2017
|
|
10 |
p. 693-694
2 p.
|
artikel
|
| 82 |
Precision medicine in pancreatic cancer: treating every patient as an exception
|
Herbst, Brian
|
|
2019
|
|
10 |
p. 805-810
|
artikel
|
| 83 |
Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study
|
Bethea, Emily D
|
|
2019
|
|
10 |
p. 771-780
|
artikel
|
| 84 |
Prevalence of occult hepatitis B virus infection in adults: a systematic review and meta-analysis
|
Im, Yu Ri
|
|
|
|
10 |
p. 932-942
|
artikel
|
| 85 |
Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis
|
Kuo, Yu-Ting
|
|
2017
|
|
10 |
p. 707-715
9 p.
|
artikel
|
| 86 |
Procalcitonin-guided reduction of antibiotic use in acute pancreatitis
|
Capurso, Gabriele
|
|
|
|
10 |
p. 896-897
|
artikel
|
| 87 |
Proximal serrated polyp detection rate and interval post-colonoscopy colorectal cancer risk
|
Asokkumar, Ravishankar
|
|
|
|
10 |
p. 907
|
artikel
|
| 88 |
Proximal serrated polyp detection rate and interval post-colonoscopy colorectal cancer risk – Authors' reply
|
Ijspeert, Joep E G
|
|
|
|
10 |
p. 907-908
|
artikel
|
| 89 |
Psychological therapies in inflammatory bowel disease
|
Shin, Andrea
|
|
|
|
10 |
p. 865-866
|
artikel
|
| 90 |
Research in Brief
|
Baker, Holly
|
|
|
|
10 |
p. 909
|
artikel
|
| 91 |
Research in brief
|
Baker, Holly
|
|
2017
|
|
10 |
p. 702-
1 p.
|
artikel
|
| 92 |
Research in brief
|
Baker, Holly
|
|
2018
|
|
10 |
p. 667
|
artikel
|
| 93 |
Research in brief
|
Baker, Holly
|
|
2019
|
|
10 |
p. 757
|
artikel
|
| 94 |
Research in Brief
|
Baker, Holly
|
|
|
|
10 |
p. 783
|
artikel
|
| 95 |
Research in brief
|
Baker, Holly
|
|
|
|
10 |
p. 889
|
artikel
|
| 96 |
Research in Brief
|
Baker, Holly
|
|
|
|
10 |
p. 876
|
artikel
|
| 97 |
Risankizumab: a game changer in Crohn's disease?
|
Gecse, Krisztina B
|
|
2018
|
|
10 |
p. 656-657
|
artikel
|
| 98 |
Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study
|
Feagan, Brian G
|
|
2018
|
|
10 |
p. 671-680
|
artikel
|
| 99 |
Safety and efficacy of BI 695501 versus adalimumab reference product in patients with advanced Crohn's disease (VOLTAIRE-CD): a multicentre, randomised, double-blind, phase 3 trial
|
Hanauer, Stephen
|
|
|
|
10 |
p. 816-825
|
artikel
|
| 100 |
Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trial
|
Kårhus, Martin L
|
|
|
|
10 |
p. 922-931
|
artikel
|
| 101 |
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study
|
Jones, David
|
|
2017
|
|
10 |
p. 716-726
11 p.
|
artikel
|
| 102 |
Shifting paradigms in the systemic management of hepatocellular carcinoma
|
Pinato, David J
|
|
|
|
10 |
p. 883-885
|
artikel
|
| 103 |
Sleep and liver disease: a bidirectional relationship
|
Marjot, Thomas
|
|
|
|
10 |
p. 850-863
|
artikel
|
| 104 |
Sofosbuvir plus ribavirin and sofosbuvir plus ledipasvir in patients with genotype 1 or 3 hepatitis C virus and severe renal impairment: a multicentre, phase 2b, non-randomised, open-label study
|
Lawitz, Eric
|
|
|
|
10 |
p. 918-926
|
artikel
|
| 105 |
Speaking up, ending stigma
|
Thorley, Jennifer
|
|
2017
|
|
10 |
p. 704-
1 p.
|
artikel
|
| 106 |
Spore-forming probiotics for functional dyspepsia
|
Burns, Grace L
|
|
|
|
10 |
p. 772-773
|
artikel
|
| 107 |
Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): an open-label, single-centre, randomised controlled trial
|
Basnayake, Chamara
|
|
|
|
10 |
p. 890-899
|
artikel
|
| 108 |
Surgery in Crohn's disease: patients need MDT-led holistic care
|
Senior, Kathryn
|
|
|
|
10 |
p. 874
|
artikel
|
| 109 |
Surgery versus infliximab for Crohn's disease: should there be a change in clinical practice?
|
Arebi, Naila
|
|
|
|
10 |
p. 877-878
|
artikel
|
| 110 |
Surgical versus non-surgical management for patients with malignant bowel obstruction (S1316): a pragmatic comparative effectiveness trial
|
Krouse, Robert S
|
|
|
|
10 |
p. 908-918
|
artikel
|
| 111 |
The crisis in clinical training for addiction
|
Gilmore, Ian
|
|
2019
|
|
10 |
p. 751-754
|
artikel
|
| 112 |
The eosinophil paradox in type 2 high upper gastrointestinal disease
|
Lipworth, Brian
|
|
|
|
10 |
p. 873
|
artikel
|
| 113 |
The lottery of primary care for liver disease
|
The Lancet Gastroenterology & Hepatology,
|
|
|
|
10 |
p. 771
|
artikel
|
| 114 |
The microbiota–gut–brain axis in obesity
|
Torres-Fuentes, Cristina
|
|
2017
|
|
10 |
p. 747-756
10 p.
|
artikel
|
| 115 |
The Patient Doctor
|
Sherwood-Martin, Hollie
|
|
|
|
10 |
p. 878
|
artikel
|
| 116 |
The public health challenge of liver cancer in Mongolia
|
Znaor, Ariana
|
|
2018
|
|
10 |
p. 660-662
|
artikel
|
| 117 |
The status quo of gastroenterology training in the UK
|
Malik, Nabihah
|
|
|
|
10 |
p. 781
|
artikel
|
| 118 |
The subjective decision of cessation of colorectal cancer screening
|
Daniel, Casey L
|
|
2017
|
|
10 |
p. 698-699
2 p.
|
artikel
|
| 119 |
The world is failing on hunger
|
The Lancet Gastroenterology & Hepatology,
|
|
|
|
10 |
p. 895
|
artikel
|
| 120 |
Time to change approaches to Helicobacter pylori management
|
Mégraud, Francis
|
|
2017
|
|
10 |
p. 692-693
2 p.
|
artikel
|
| 121 |
Time to scale up testing and treatment for HBV and HCV in the WHO Eastern Mediterranean Region
|
Alaama, Ahmed Sabry
|
|
|
|
10 |
p. 868-870
|
artikel
|
| 122 |
Treating bile acid diarrhoea with liraglutide
|
Walters, Julian R F
|
|
|
|
10 |
p. 897-899
|
artikel
|
| 123 |
Upper gastrointestinal endoscopy: can we cut the cord?
|
Tai, Foong Way David
|
|
2019
|
|
10 |
p. 749-751
|
artikel
|
| 124 |
Warburg: father of the metabolic approach to cancer
|
Wortley, Chris
|
|
|
|
10 |
p. 911
|
artikel
|
| 125 |
What is normal and abnormal in lactose digestion?
|
Misselwitz, Benjamin
|
|
2017
|
|
10 |
p. 696-697
2 p.
|
artikel
|
| 126 |
When clean eating goes dirty
|
Staudacher, Heidi M
|
|
2018
|
|
10 |
p. 668
|
artikel
|
| 127 |
WHO 2030 HBV elimination goals: a goal too far?
|
Lim, Seng Gee
|
|
|
|
10 |
p. 862-863
|
artikel
|
| 128 |
Widespread hepatitis A outbreaks in the USA strain public health agencies
|
Furlow, Bryant
|
|
2019
|
|
10 |
p. 755-756
|
artikel
|
| 129 |
William Arbuthnot Lane: kink catastrophe
|
Burki, Talha Khan
|
|
2018
|
|
10 |
p. 670
|
artikel
|
Tijdschrift beschrijving